Healthcare New Highs: Johnson & Johnson (NYSE:JNJ), CONMED Corporation (NASDAQ:CNMD), Select Medical Holdings (NYSE:SEM), Heska Corp (NASDAQ:HSKA)

Johnson & Johnson (NYSE:JNJ) stock had its “buy” rating reaffirmed by equities research analysts at Citigroup Inc. in a research note issued to investors on Wednesday, StockRatingsNetwork reports. They currently have a $114.00 price target on the stock. Citigroup Inc.’s price objective would suggest a potential upside of 14.92% from the company’s current price. Johnson & Johnson (NYSE:JNJ), shares after opening at $99.57 moved to $99.71 on last trade day and at the end of the day closed at $98.75. Company price to sales ratio in past twelve months was calculated as 3.92 and price to cash ratio as 9.56. Johnson & Johnson (NYSE:JNJ), showed a negative weekly performance of 0.20%.

CONMED Corporation (NASDAQ:CNMD), was a big mover last session, as the company saw its shares rise by over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $42.23 to $45.95 in the past one-month time frame. CONMED Corporation (NASDAQ:CNMD), shares advanced 6.54% in last trading session and ended the day on $48.21. CONMED Corporation (NASDAQ:CNMD), return on equity ratio is recorded as 6.00% and its return on assets is 3.30%. CONMED Corporation (NASDAQ:CNMD), yearly performance is 52.42%.

On April 1, 2014, shares of Select Medical Holdings Corporation (NYSE:SEM), reached a new 52-week high of $12.72. Shares gained almost 48.1% in the 1-year period. Select Medical Holdings Corporation (NYSE:SEM), shares moved down 1.08% in last trading session and was closed at $13.75, while trading in range of $ 13.61 – 14.29. Select Medical Holdings Corporation (NYSE:SEM), year to date (YTD) performance is 19.46%.

Heska Corp (NASDAQ:HSKA), Director Carol Wrenn acquired 1,000 shares of the company’s stock on the open market in a transaction dated Monday, March 31st. The shares were purchased at an average cost of $10.50 per share, for a total transaction of $10,500.00. Following the completion of the purchase, the director now directly owns 4,000 shares of the company’s stock, valued at approximately $42,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Heska Corp (NASDAQ:HSKA), weekly performance is 10.05%. On last trading day company shares ended up $12.26. Heska Corp (NASDAQ:HSKA), distance from 50-day simple moving average (SMA50) is 25.88%. Analysts mean target Price for the company is $13.08.